A new approach to help young adults lose weight

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a behavioral intervention combined with technology to promote weight loss in young adults aged 18 to 40. Participants will engage in a 6-month program that includes regular clinic visits, tracking their weight and food intake through a smartphone app, and wearing a wrist activity monitor. They will also receive guidance from a trained coach to support their weight loss journey. The study aims to determine how these combined strategies influence weight loss outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Overweight or obese (BMI 25.5- 34.9 kg/m2) men and women
* Ages 18 to 40 years
* Weight stable (no change \>25 lbs in the past 3 months)
* Owns a smartphone and willing to install the study app

Exclusion Criteria:

* Presence of obstructive sleep apnea or history of any other sleep disorder.
* Irregular menses, menopausal symptoms or post-menopausal, currently pregnant, trying to get pregnant or nursing
* Regular travel across time zones
* Subjects who are currently following a weight loss regimen or any other special diet or exercise programs
* Increased fractional lean body mass (e.g., athletes)
* Unable to walk, using an assistive device for mobility, or any contraindications to exercise
* Diabetes
* Claustrophobia
* Excessive alcohol (\>2 drinks/day) or caffeine (\>300mg/day) intake, regular nicotine use, substance abuse.
* Abnormal findings on screening blood testing.
* Participants taking any prescription, over-the-counter drugs/supplements that can affect sleep or weight.
* Major psychiatric or any eating disorder, and any acute or chronic medical condition that increase the risk of interventions (e.g., heart disease)
* Any underlying disease likely to limit life span and/or increase risk of interventions including cardiovascular disease (e.g. unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class\>2), pulmonary disease with dependence on oxygen or daily use of bronchodilators, cancer requiring treatment in the past 5 years unless the prognosis is considered good, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly), hepatitis or other chronic gastrointestinal disease (pancreatitis, inflammatory bowel disease), renal disease, significant anemia, recent surgery or significant abdominal surgery, major psychiatric or any eating disorder, acute coronary syndrome or stroke in the past 6 months

Where it's running

• University of Chicago
  Chicago, Illinois, United States Recruiting

Study contacts

• Principal investigator: Esra Tasali, MD — University of Chicago
• Study coordinator: Olivia Hughes
• Email: bhughes8@bsd.uchicago.edu
• Phone: 7737022348

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 15-year outcomes after sleeve gastrectomy in France

  This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT07883018

• Do GLP-1 medicines affect breastmilk production and milk quality after pregnancy

  This study will test whether weight loss from injected GLP-1 receptor agonists changes how much milk moms produce or the nutritional makeup of their breast milk.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT07720414

• Personalized 26-week program to help keep weight off

  This 26-week program tests whether tailored messages, weekly check-ins and weighing, and optional health coaching help adults who recently lost at least 7% of their weight keep it off.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07577765

• HRS9531 PK in adults with different liver function

  This Phase 1 study tests how HRS9531 behaves in the body and whether it is safe in people with mild, moderate liver impairment and those with normal liver function.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Zhengzhou, Henan · NCT07540754

• Fasted versus fed aerobic exercise for weight loss and heart health

  This 16-week program will see if doing aerobic exercise before breakfast (fasted) versus after eating helps adults with overweight or obesity lose more weight and improve heart-related measures.

  Recruiting Phase 2 Arkansas Colleges of Health Education · Fort Smith, Arkansas · NCT07487090

• Multi-strain Bacillus probiotic for cesarean-delivered newborns

  This study tests whether daily multi-strain Bacillus spore probiotics help cesarean-born newborns grow better and have fewer tummy troubles by supporting a healthier gut microbiota.

  Recruiting Anabio R&D · Hanoi · NCT07320287

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.